Perspective Therapeutics (FRA:AAJ0) Operating Cash Flow per Share : €-0.72 (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Operating Cash Flow per Share?

Perspective Therapeutics's operating cash flow per share for the three months ended in Mar. 2025 was €-0.28. Perspective Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.72.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Perspective Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

FRA:AAJ0' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -358.2 Med: 8.95 Max: 72.7
Current: -1.3

During the past 13 years, Perspective Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.70% per year. The lowest was -358.20% per year. And the median was 8.95% per year.

FRA:AAJ0's 3-Year OCF Growth Rate is ranked worse than
63.79% of 696 companies
in the Medical Devices & Instruments industry
Industry Median: 8.3 vs FRA:AAJ0: -1.30

Perspective Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Perspective Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Operating Cash Flow per Share Chart

Perspective Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.48

-0.23

-0.51

-1.27

-0.27

Perspective Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.26	-0.12	0.04	-0.36	-0.28

Competitive Comparison of Perspective Therapeutics's Operating Cash Flow per Share

For the Medical Devices subindustry, Perspective Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perspective Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Perspective Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Perspective Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-17.471	/	64.425
	=	-0.27

Perspective Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-19.963	/	72.357
	=	-0.28

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.72

Perspective Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ0) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CATX:USA AAJ0:Germany

Address

2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121

Website

https://www.perspectivetherapeutics.com

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Therapeutics Headlines

No Headlines